Abstract : Nanotechnology has become a game changer, with substantial implications for human health and illness treatment. Nanoparticles, with their distinctive physiochemical properties have opened up interesting new possibilities in the domains of therapeutics, drug delivery, bio-imaging, and diagnostics. In the field of diagnostics, nanoparticles enable the expansion of exceptionally sensitive and targeted biosensors for early detection of disease. They serve as therapeutic agent carriers, allowing for targeted drug administration and reducing systemic side effects. Furthermore, nanoparticles have revolutionized diagnostic approaches, improving the resolution and accuracy of tests such as magnetic resonance imaging (MRI) and computed tomography (CT) scans. Nanobiotechnology has potential uses in oncology, infectious diseases, neurological disorders, and regenerative medicine. Nanoparticles can be designed to target specific tissue, allowing chemotherapeutic drugs to be delivered directly to tumors. However, understanding nanoparticle toxicity and long-term effects is crucial for safe clinical translation. This chapter presents an overview of nanobiotechnology critical role in addressing multiple facets of human health and disease management.
Keywords : Nanobiotechnology, nanomedicine, cancer therapy, virus detection, Bioimaging
Cite : Kumar, N., Choudhary, K., & Kumar, S. (2023). Biomedical Nanotechnology: The Promising Impacts Of Nanobiotechnology On Human Health And Disease Management (1st ed., p. 123). Noble Science Press. https://doi.org/10.52458/9789388996846.nsp2023.eb.ch-16
References :
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008). Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol. Pharmaceutics. 5: 505-515.
Allen, T. M., & Cullis, P. R. (2013). Liposomal drug delivery systems: from concept to clinical applications. Advanced drug delivery reviews, 65(1), 36-48.
Bamrungsap, S., Zhao, Z., Chen, T., Wang, L., Li, C., Fu, T., & Tan, W. (2012). Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system. Nanomedicine, 7(8), 1253-1271.
Bhaskar, S., Tian, F., Stoeger, T., Kreyling, W., de la Fuente, J. M., Grazú, V., ... & Razansky, D. (2010). Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging. Particle and fibre toxicology, 7(1), 1-25.
Chen, Y., & Feng, X. (2022). Gold nanoparticles for skin drug delivery. International Journal of Pharmaceutics, 122122.
De, M., Ghosh, P. S., & Rotello, V. M. (2008). Applications of nanoparticles in biology. Advanced Materials, 20(22), 4225-4241.
Dreaden, E. C., Alkilany, A. M., Huang, X., Murphy, C. J., & El-Sayed, M. A. (2012). The golden age: gold nanoparticles for biomedicine. Chemical Society Reviews, 41(7), 2740-2779.
Gabizon, A., Shmeeda, H., & Barenholz, Y. (2003). Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies. Clinical pharmacokinetics, 42, 419-436.
Gelperina, S., Kisich, K., Iseman, M. D., & Heifets, L. (2005). The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. American journal of respiratory and critical care medicine, 172(12), 1487-1490.
Gradishar, W. J., Tjulandin, S., Davidson, N., Shaw, H., Desai, N., Bhar, P., ... & O'Shaughnessy, J. (2005). Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil–based paclitaxel in women with breast cancer. Journal of clinical oncology, 23(31), 7794-7803.
Gu, W., Wu, C., Chen, J., & Xiao, Y. (2013). Nanotechnology in the targeted drug delivery for bone diseases and bone regeneration. International journal of nanomedicine, 2305-2317.
Jabbari, A., & Sadeghian, H. (2012). Amphiphilic cyclodextrins, synthesis, utilities and application of molecular modeling in their design. Recent Advances in Novel Drug Carrier Systems, 331-354.
Jain, K. K. (2008). Drug delivery systems-an overview. Drug delivery systems, 1-50.
Kanasty, R., Dorkin, J. R., Vegas, A., & Anderson, D. (2013). Delivery materials for siRNA therapeutics. Nature materials, 12(11), 967-977.
Kaparissides, C., Alexandridou, S., Kotti, K., & Chaitidou, S. (2006). Recent advances in novel drug delivery systems. Journal of Nanotechnology online, 2, 1-11.
Kircher, M. F., Mahmood, U., King, R. S., Weissleder, R., & Josephson, L. (2003). A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer research, 63(23), 8122-8125.
Kompella, U. B., Amrite, A. C., Ravi, R. P., & Durazo, S. A. (2013). Nanomedicines for back of the eye drug delivery, gene delivery, and imaging. Progress in retinal and eye research, 36, 172-198.
Loureiro, A., G Azoia, N., C Gomes, A., & Cavaco-Paulo, A. (2016). Albumin-based nanodevices as drug carriers. Current pharmaceutical design, 22(10), 1371-1390.
Ma, B., Chen, Y., Hu, G., Zeng, Q., Lv, X., Oh, D. H., ... & Jin, Y. (2021). Ovotransferrin antibacterial peptide coupling mesoporous silica nanoparticle as an effective antibiotic delivery system for treating bacterial infection in vivo. ACS Biomaterials Science & Engineering, 8(1), 109-118.
Maeda, H., Nakamura, H., & Fang, J. (2013). The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. Advanced drug delivery reviews, 65(1), 71-79.
Margolis, D. J., Hoffman, J. M., Herfkens, R. J., Jeffrey, R. B., Quon, A., & Gambhir, S. S. (2007). Molecular imaging techniques in body imaging. Radiology, 245(2), 333-356.
Martis, E., Badve, R., & Degwekar, M. (2012). Nanotechnology based devices and applications in medicine: An overview. Chronicles of young Scientists, 3(1), 68-68.
Meng, E., & Hoang, T. (2012). Micro-and nano-fabricated implantable drug-delivery systems. Therapeutic delivery, 3(12), 1457-1467.
Mukherjee, B., Dey, N. S., Maji, R., Bhowmik, P., Das, P. J., & Paul, P. (2014). Current status and future scope for nanomaterials in drug delivery. In Application of nanotechnology in drug delivery. IntechOpen.
Nikalje, A. P. (2015). Nanotechnology and its applications in medicine. Med chem, 5(2), 081-089.
Ochekpe, N. A., Olorunfemi, P. O., & Ngwuluka, N. C. (2009). Nanotechnology and drug delivery part 1: background and applications. Tropical journal of pharmaceutical research, 8(3).
Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodriguez-Torres, M. D. P., Acosta-Torres, L. S., ... & Shin, H. S. (2018). Nano based drug delivery systems: recent developments and future prospects. Journal of nanobiotechnology, 16(1), 1-33.
Peng, L. H., Huang, Y. F., Zhang, C. Z., Niu, J., Chen, Y., Chu, Y., ... & Mao, Z. W. (2016). Integration of antimicrobial peptides with gold nanoparticles as unique non-viral vectors for gene delivery to mesenchymal stem cells with antibacterial activity. Biomaterials, 103, 137-149.
Popovtzer, R., Agrawal, A., Kotov, N. A., Popovtzer, A., Balter, J., Carey, T. E., & Kopelman, R. (2008). Targeted gold nanoparticles enable molecular CT imaging of cancer. Nano letters, 8(12), 4593-4596.
Quan, Q., & Zhang, Y. (2015). Lab-on-a-Tip (LOT): Where nanotechnology can revolutionize fibre optics. Nanobiomedicine, 2, 3.
Rathinaraj, P., Al-Jumaily, A. M., & Huh, D. S. (2015). Internalization: acute apoptosis of breast cancer cells using herceptin-immobilized gold nanoparticles. Breast Cancer: Targets and Therapy, 51-58.
Sakamoto, J. H., van de Ven, A. L., Godin, B., Blanco, E., Serda, R. E., Grattoni, A., ... & Ferrari, M. (2010). Enabling individualized therapy through nanotechnology. Pharmacological research, 62(2), 57-89.
Saraiva, C., Praça, C., Ferreira, R., Santos, T., Ferreira, L., & Bernardino, L. (2016). Nanoparticle-mediated brain drug delivery: Overcoming blood–brain barrier to treat neurodegenerative diseases. Journal of controlled release, 235, 34-47.
Schellenberger, E. A.; Sosnovik, D.; Weissleder, R.; Josephson, L. Magneto/Optical Annexin V, A Multimodal Protein. Bioconjug. Chem. 2004, 15, 1062–1067.
Sharma, P., Brown, S., Walter, G., Santra, S., & Moudgil, B. (2006). Nanoparticles for bioimaging. Advances in colloid and interface science, 123, 471-485.
Singh, M., Singh, S., Prasad, S., & Gambhir, I. S. (2008). Nanotechnology in medicine and antibacterial effect of silver nanoparticles. Digest Journal of Nanomaterials and Biostructures, 3(3), 115-122.
Sultan, M. H., Moni, S. S., Madkhali, O. A., Bakkari, M. A., Alshahrani, S., Alqahtani, S. S.,... & Alshamrani, M. (2022). Characterization of cisplatin-loaded chitosan nanoparticles and rituximab-linked surfaces as target-specific injectable nano-formulations for combating cancer. Scientific reports, 12(1), 468.
Tan, W., Wang, K., He, X., Zhao, X. J., Drake, T., Wang, L., & Bagwe, R. P. (2004). Bionanotechnology based on silica nanoparticles. Medicinal research reviews, 24(5), 621-638.
Wagner, V., & Dullaart, A. (2006). Bock, AK & Zweck, A. The emerging nanomedicine landscape. Nat Biotechnol, 24, 1211-1217.
Weissleder, R. (2002). Scaling down imaging: molecular mapping of cancer in mice. Nature Reviews Cancer, 2(1), 11-18.
Xu, Q., Kambhampati, S. P., & Kannan, R. M. (2013). Nanotechnology approaches for ocular drug delivery. Middle East African journal of ophthalmology, 20(1), 26.
